Enhancing Resilience Among Patients With Stroke: Implementation of High Intensity Home-based Rehabilitation
Launched by DUKE UNIVERSITY · Jul 25, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study is looking at a new way to help people recover after a stroke by providing high-intensity rehabilitation services at home, instead of sending them to a rehab facility. The researchers want to see if patients who get this home-based therapy recover their abilities just as well as those who go to an inpatient rehab center. This study will include patients who have had a stroke, are between 65 and 74 years old, and are being discharged from Duke University Hospital to their home in Durham County.
To join the study, patients need to be able to read and understand English, have a certain level of stroke severity and mobility, need rehab care from at least two types of therapy, and have enough support from caregivers at home to be safe. Participants won’t be assigned to different groups; instead, those who choose home rehab will be followed to see how they do compared to others who go to a rehab facility. This study is not yet recruiting, but it aims to help doctors understand if home-based rehab can be a good option for stroke recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ability to read and understand English.
- • Admitted to Duke University Hospital stroke medical service
- • Confirmed diagnosis of stroke (per documentation in medical record)
- * At time of hospital discharge:
- • a) Home address in Durham County b) NIH Stroke Scale Score = 4-13 c) AM-PAC 6-Clicks basic mobility score \>/=13 d) Documented need for post-acute rehabilitation from 2 disciplines e) No contraindications to safe medical management at home (ongoing cancer treatment, dialysis-dependent ESRD, complex wounds, others as determined by the attending medical team) g) Clinically judged to have adequate caregiver support at home
- Exclusion Criteria:
- • Those with acute psychosis or an inability to provide legal and effective consent will be excluded from participation.
- • Those with medical contraindications as determined by the hospital attending neurology team
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Joshua K. Johnson, DPT, PhD
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported